Back to Search
JENNIFER SCHRANZ, M.D.
M.D.
Infectious Disease Physician
NPI: 1932462652Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD067019-L(PA)
Research & Publications (8)
A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
PMID 18545153·J Acquir Immune Defic Syndr·2008
3-trial
Anidulafungin versus fluconazole for invasive candidiasis.
PMID 17568028·N Engl J Med·2007
4-observational
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
PMID 17049677·Vaccine·2007
8-other
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.
PMID 16436720·Antimicrob Agents Chemother·2006
4-observational
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
PMID 16291712·J Clin Pharmacol·2005
2-rct
[Bronchial obstruction by an aberrant left pulmonary artery misdiagnosed as asthma in a 7 year old child].
PMID 15211253·Rev Mal Respir·2004
5-case
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
PMID 12821458·Antimicrob Agents Chemother·2003
3-trial
Aspergillosis case-fatality rate: systematic review of the literature.
PMID 11170942·Clin Infect Dis·2001
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 51 GOLDFINCH CIRCLE
PHOENIXVILLE, PA 19460 - Phone
- (610) 585-6294
Quick Facts
- NPI
- 1932462652
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile